The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126018011 12601801 1 I 2011 20160715 20160728 20160728 PER US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-46783BP BOEHRINGER INGELHEIM 77.13 YR F Y 0.00000 20160728 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126018011 12601801 1 PS COMBIVENT ALBUTEROL SULFATEIPRATROPIUM BROMIDE 1 Respiratory (inhalation) DOSE PER APPLICATION AND DAILY DOSE: 18 MCG / 103 MCG 265559A,501047B 21747 INHALATION SOLUTION
126018011 12601801 2 SS COMBIVENT ALBUTEROL SULFATEIPRATROPIUM BROMIDE 1 Respiratory (inhalation) DOSE PER APPLICATION AND DAILY DOSE : 20 MCG / 100 MCG; FORMULATION: INHALATION SPRAY 265559A,501047B 21747 PRESSURISED INHALATION QD
126018011 12601801 3 SS STIOLTO RESPIMAT OLODATEROL HYDROCHLORIDETIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 2.5 MCG Y 501877A 206756 2.5 UG PRESSURISED INHALATION QD
126018011 12601801 4 C Amlodipine Besalate 2 Oral 5 MG 0 5 MG TABLET QD
126018011 12601801 5 C RANITIDINE. RANITIDINE 1 Oral 150 MG 0 150 MG TABLET QD
126018011 12601801 6 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 125 MG 0 125 MG TABLET QD
126018011 12601801 7 C BUPROPRION BUPROPION 1 Oral 300 MG 0 150 MG CAPSULE BID
126018011 12601801 8 C Atorvastatin ATORVASTATIN 1 Oral 20 MG 0 20 MG TABLET QD
126018011 12601801 9 C METOPROLOL. METOPROLOL 1 Oral 50 MG 0 50 MG TABLET QD
126018011 12601801 10 C LOSARTAN. LOSARTAN 1 Oral 100 MG 0 100 MG TABLET QD
126018011 12601801 11 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown 20 MG 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126018011 12601801 1 Asthma
126018011 12601801 3 Asthma
126018011 12601801 4 Hypertension
126018011 12601801 5 Gastrooesophageal reflux disease
126018011 12601801 6 Hypothyroidism
126018011 12601801 7 Depression
126018011 12601801 8 Blood cholesterol increased
126018011 12601801 9 Hypertension
126018011 12601801 10 Hypertension
126018011 12601801 11 Gastrooesophageal reflux disease

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126018011 12601801 Cough
126018011 12601801 Off label use
126018011 12601801 Productive cough

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126018011 12601801 1 2011 20151230 0
126018011 12601801 2 20151230 0
126018011 12601801 3 201605 20160711 0
126018011 12601801 4 2016 0
126018011 12601801 5 2011 0
126018011 12601801 6 1996 0
126018011 12601801 7 1995 0
126018011 12601801 8 2015 0
126018011 12601801 9 2015 0
126018011 12601801 10 2010 0
126018011 12601801 11 2011 0